Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan L Epstein

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Hybridoma and Hybridomics|February 8, 2003
Generation of human interferon gamma and tumor Necrosis factor alpha chimeric TNT-3 fusion proteinsJahangir Sharifi, Leslie A Khawli, Peisheng Hu, et al.
The Journal of Rheumatology|February 3, 2011
Rapidly fatal pulmonary fibrosis in a patient with psoriatic arthritis treated with adalimumabJustine V Cohen, Brian C Capell, Paul A Kinniry, et al.
Blood|March 1, 2003
Generation of low-toxicity interleukin-2 fusion proteins devoid of vasopermeability activityPeisheng Hu, Myra Mizokami, Gina Ruoff, et al.
Journal of Cancer Science & Therapy|December 5, 2015
Phase 1 Dose-Escalation Study with LEC/chTNT-3 and Toceranib Phosphate (Palladia<sup>®</sup>) in Dogs with Spontaneous MalignanciesJulie K Jang, John Chretin, David Bruyette, et al.
Immunotherapy|November 8, 2011
Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumorsMelissa G Lechner, Sarah M Russell, Rikki S Bass, et al.
Hybridoma and Hybridomics|September 27, 2003
Chimeric TNT-3 antibody/murine interferon-gamma fusion protein for the immunotherapy of solid malignanciesMyra M Mizokami, Peisheng Hu, Leslie A Khawli, et al.
Cancer Immunology, Immunotherapy : CII|June 28, 2025
Simultaneous TGF-β and GITR pathway modulation promotes anti-tumor immunity in gliomaDaniela Lorizio, Manuela Silginer, Julia Friesen, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 25, 2002
Pharmacokinetic characteristics and biodistribution of radioiodinated chimeric TNT-1, -2, and -3 monoclonal antibodies after chemical modification with biotinLeslie A Khawli, Myra M Mizokami, Jahangir Sharifi, et al.
Journal of the National Cancer Institute|May 22, 2003
Identification of a protein fragment of interleukin 2 responsible for vasopermeabilityAlan L Epstein, Myra M Mizokami, Jiali Li, et al.
Leukemia & Lymphoma|May 10, 2007
Combination immunotherapy with anti-CD20 and anti-HLA-DR monoclonal antibodies induces synergistic anti-lymphoma effects in human lymphoma cell linesEvan Tobin, Gerald Denardo, Nan Zhang, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Hybridoma and Hybridomics|February 8, 2003
Generation of human interferon gamma and tumor Necrosis factor alpha chimeric TNT-3 fusion proteinsJahangir Sharifi, Leslie A Khawli, Peisheng Hu, et al.
The Journal of Rheumatology|February 3, 2011
Rapidly fatal pulmonary fibrosis in a patient with psoriatic arthritis treated with adalimumabJustine V Cohen, Brian C Capell, Paul A Kinniry, et al.
Blood|March 1, 2003
Generation of low-toxicity interleukin-2 fusion proteins devoid of vasopermeability activityPeisheng Hu, Myra Mizokami, Gina Ruoff, et al.
Journal of Cancer Science & Therapy|December 5, 2015
Phase 1 Dose-Escalation Study with LEC/chTNT-3 and Toceranib Phosphate (Palladia<sup>®</sup>) in Dogs with Spontaneous MalignanciesJulie K Jang, John Chretin, David Bruyette, et al.
Immunotherapy|November 8, 2011
Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumorsMelissa G Lechner, Sarah M Russell, Rikki S Bass, et al.
Hybridoma and Hybridomics|September 27, 2003
Chimeric TNT-3 antibody/murine interferon-gamma fusion protein for the immunotherapy of solid malignanciesMyra M Mizokami, Peisheng Hu, Leslie A Khawli, et al.
Cancer Immunology, Immunotherapy : CII|June 28, 2025
Simultaneous TGF-β and GITR pathway modulation promotes anti-tumor immunity in gliomaDaniela Lorizio, Manuela Silginer, Julia Friesen, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 25, 2002
Pharmacokinetic characteristics and biodistribution of radioiodinated chimeric TNT-1, -2, and -3 monoclonal antibodies after chemical modification with biotinLeslie A Khawli, Myra M Mizokami, Jahangir Sharifi, et al.
Journal of the National Cancer Institute|May 22, 2003
Identification of a protein fragment of interleukin 2 responsible for vasopermeabilityAlan L Epstein, Myra M Mizokami, Jiali Li, et al.
Leukemia & Lymphoma|May 10, 2007
Combination immunotherapy with anti-CD20 and anti-HLA-DR monoclonal antibodies induces synergistic anti-lymphoma effects in human lymphoma cell linesEvan Tobin, Gerald Denardo, Nan Zhang, et al.
Pageof 10